Royal Bank of Canada
AYTU icon

Royal Bank of Canada’s AYTU BioPharma AYTU Stock Holding History

Royal Bank of Canada’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
36
+11
+44% +$28 ﹤0.01% 7105
2025
Q4 		$0 Buy
+25
New +$56 ﹤0.01% 7157
2024
Q3 		– Sell
-3,285
Closed -$10K – 6840
2024
Q2 		$10K Buy
3,285
+576
+21% +$1.74K ﹤0.01% 6322
2024
Q1 		$8K Sell
2,709
-890
-25% -$2.55K ﹤0.01% 6271
2023
Q4 		$10K Buy
3,599
+3,448
+2,283% +$9.5K ﹤0.01% 6484
2023
Q3 		$0 Sell
151
-121
-44% -$212 ﹤0.01% 7071
2023
Q2 		$0 Buy
272
+249
+1,083% +$489 ﹤0.01% 7236
2023
Q1 		$0 Sell
23
-3
-12% -$9 ﹤0.01% 7060
2022
Q4 		$0 Buy
26
+2
+8% +$8 ﹤0.01% 7209
2022
Q3 		$0 Hold
24
– – ﹤0.01% 7431
2022
Q2 		$0 Hold
24
– – ﹤0.01% 7360
2022
Q1 		$1K Sell
24
-1
-4% -$25 ﹤0.01% 7566
2021
Q4 		$1K Sell
25
-4
-14% -$173 ﹤0.01% 7476
2021
Q3 		$1K Sell
29
-259
-90% -$19.4K ﹤0.01% 7448
2021
Q2 		$29K Buy
288
+188
+188% +$22.1K ﹤0.01% 6359
2021
Q1 		$15K Buy
100
+91
+1,011% +$14.4K ﹤0.01% 6590
2020
Q4 		$1K Buy
+9
New +$1.64K ﹤0.01% 6920
2020
Q3 		– Hold
0
– – – 6608
2020
Q2 		– Sell
-2
Closed -$1K – 6612
2020
Q1 		$1K Buy
+2
New +$386 ﹤0.01% 6397
2019
Q4 		– Sell
-1
Closed – – 6813
2019
Q3 		$0 Buy
+1
New +$301 ﹤0.01% 6688
2018
Q1 		– Hold
0
– – – 6333
2017
Q4 		– Hold
0
– – – 6532

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's AYTU Position: Q1 2026 in Review

Royal Bank of Canada increased its AYTU BioPharma (AYTU) stake by 44% in Q1 2026, buying an estimated $28 and bringing the position to 36 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7105.

Royal Bank of Canada first reported a position in AYTU in Q3 2019 and has held it in 19 quarters since. The position peaked at $29K in Q2 2021. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • Royal Bank of Canada held 36 shares of AYTU BioPharma worth $0 as of Q1 2026.
  • Royal Bank of Canada bought 11 AYTU BioPharma shares in Q1 2026, an estimated $28.
  • AYTU BioPharma made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7105 holding.
  • Royal Bank of Canada first reported a position in AYTU BioPharma in Q3 2019 and has held it in 19 quarters since.
  • Royal Bank of Canada's AYTU BioPharma position peaked at $29K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.